Table 1 Baseline Characteristics of the Patients (N = 60)
Demographic profile: | Liraglutide, N = 30 | Dulaglutide, N = 30 | P value | |
|---|---|---|---|---|
Male, n (%) | 28(46.7%) | 13 (43.3%) | 15 (50%) | 0.605 |
Female, n (%) | 32 (53.3%) | 17 (56.7%) | 15 (50%) | |
Age(years), Mean ± SEM | 47.75 ± 1.22 | 47.33 ± 1.91 | 48.17 ± 1.55 | 0.736 |
Height (centimeters), Mean ± SEM | 161.53 ± 1.2 | 159.97 ± 1.52 | 163.10 ± 1.83 | 0.193 |
Body weight(Kg), Mean ± SEM | 88.3 ± 1.68 | 89.43 ± 2.60 | 87.17 ± 2.16 | 0.506 |
Diabetes duration, (years), Mean ± SEM | 6.07 ± 0.70 | 5.55 ± 0.94 | 6.59 ± 1.03 | 0.46 |
SBP(mmHg), Mean ± SEM | 136.07 ± 1.84 | 137.83 ± 2.50 | 134.30 ± 2.71 | 0.342 |
DBP(mmHg), Mean ± SEM | 82.1 ± 1.15 | 83.47 ± 1.58 | 80.73 ± 1.64 | 0.236 |
BMI(kg/m2), Mean ± SEM | 34.99 ± 5.66 | 34.92 ± 0.86 | 32.84 ± 0.77 | 0.078 |
BMI – 25 -29.9 | 10 (16.67%) | |||
BMI - 30-34.9 | 30 (50%) | |||
BMI - 35-39.9 | 12 (20%) | |||
BMI - ≥40 | 8 (13.33%) | |||
FPG(mg/dL), Mean ± SEM | 167.83 ± 7.04 | 160.13 ± 8.17 | 175.53 ± 11.45 | 0.278 |
HbA1c(%), Mean ± SEM | 8.46 ± 0.17 | 8.49 ± 0.26 | 8.43 ± 0.21 | 0.847 |
On Metformin, n (%) | 60 (100%) | 30 (100%) | 30 (100%) | 1.00 |
On SGLT-2is, n (%) | 60 (100%) | 30 (100%) | 30 (100%) | 1.00 |